Both in Pharmaceuticals
MapLight Therapeutics vs Lyell Immunopharma
Over the past year MPLT returned −58.7% and LYEL returned −3.3%; their daily moves had a correlation of 0.09.
MPLT −58.7% LYEL −3.3%Growth of $1, one year, split-adjusted
| Metric | MPLT | LYEL |
|---|---|---|
| Price | $6.71 | $15.43 |
| Market cap | $372.9M | $378.1M |
| Today | −1.47% | +43.27% |
| 1 month | −30.8% | +79.2% |
| 6 months | −76.9% | −26.0% |
| Year to date | −61.8% | −49.9% |
| 1 year | −60.3% | −6.8% |
| Revenue growth (YoY) | — | −50.0% |
| Gross margin | — | 100.0% |
| Net margin | — | −1118875.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 14,004.2× |
| Net cash | $304.7M | $204.1M |
| Dividend yield | — | — |
| Volatility (60d) | 61.1% | 101.1% |
| Short % of float | 24.6% | 15.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).